Nociceptin (also called orphanin FQ) is an endogenous heptadecapeptide that activates the opioid receptor-like 1 (ORL 1 ) receptor. Nociceptin system not only affects the nociception and locomotor activity, but also regulates learning and memory in rodents. We have previously reported that long-term potentiation and memory of ORL 1 receptor knockout mice are enhanced compared with those in wild-type mice. Here, we show the neuronal mechanism of nociceptin-induced modulation of learning and memory. Retention of fear-conditioned contextual memory was significantly enhanced in the ORL 1 receptor knockout mice without any changes in cued conditioned freezing. Inversely, in the wild-type mice retention of contextual, but not cued, conditioning freezing behavior was suppressed by exogenous nociceptin when it was administered into the cerebroventricle immediately after the training. ORL 1 receptor knockout mice exhibited a hyperfunction of N-methyl-D-aspartate (NMDA) receptor, as evidenced by an increase in [ 3 H]MK-801 binding, NMDA-evoked 45 Ca 2 þ uptake and activation of Ca 2 þ /calmodulin-dependent protein kinase II (CaMKII) activity and its phosphorylation as compared with those in wild-type mice. The NMDA-induced CaMKII activation in the hippocampal slices of wild-type mice was significantly inhibited by exogenous nociceptin via a pertussis toxin-sensitive pathway. However, the a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor GluR1 subunit at Ser 831 and Ser
Opioid receptors are negatively coupled to adenylate cyclase through Gi/o proteins and mediate the inhibition of forskolin-induced cAMP accumulation by morphine and endogenous opioid peptides. Opioid receptor agonists have receptor subtypespecific actions on not only the nociceptive thresholds but also synaptic transmission and long-term potentiation (LTP) in the hippocampus. Thus, opioid system modulates certain forms of learning and memory. 1 Nociceptin, an endogenous ligand for opioid receptor-like 1 (ORL 1 ) receptors, shares sequences with other opioid peptides, particularly with dynorphin A (53%). 2, 3 This peptide is capable of inhibiting Ca 2 þ currents through voltage-gated Ca 2 þ channels in dissociated hippocampal neurons, 4 inducing hyperpolarizing currents via inward-rectifier K þ channels in the hippocampal CA3 cells 5 or suppressing synaptic transmission in the hippocampal CA1 slices. 6 Owing to its structural similarity to classical opioids (68% homology with m receptor, 67% with d receptor, 66% with k receptor) and high density of ORL 1 receptors in the hippocampus, 7 it is of interest to explore whether nociceptin, like other opioids, modulates the synaptic plasticity and memory function in the hippocampus. Recent studies demonstrated that intrahippocampal 8, 9 and intracerebroventricular 10, 11 injections of nociceptin impair learning and memory in the water maze and passive avoidance tests, respectively. We have also reported that LTP in the hippocampal CA1 region and memory are facilitated in the ORL 1 receptor knockout mice compared to wild-type mice. [11] [12] [13] The enhanced LTP in the hippocampus of ORL 1 receptor knockout mice was blocked by AP-V, an N-methyl-D-aspartate (NMDA) receptor antagonist. 13 The overexpression of NMDA receptor subunit NR2B in transgenic mice has been reported to enhance the retention of memory and the extinction of learning in the contextual fear learning task. 14 These findings suggest that nociceptin/ORL 1 receptor system plays an important role in modulating learning and memory related with NMDA receptor function in the hippocampus. Furthermore, a-amino-3-hydroxy-5-methyl-4-isoxazloe proprionic acid (AMPA) receptor also regulates the LTP and long-term depression (LTD) with the phosphorylation and dephosphorylation of AMPA receptor GluR1 subunit. 15 However, the cellular mechanisms of crosstalk between ORL 1 and NMDA/AMPA receptors remain to be addressed.
Here, we assessed the performance in the contextual fear learning task in the ORL 1 receptor knockout mice and the wild-type mice treated with exogenous nociceptin. Next, we investigated the alteration of NMDA receptor function by nociceptin, as manifested by [ 3 H]MK-801 binding in the membrane preparations, 45 
Ca
2 þ uptake into the synaptosomes, Ca 2 þ /calmodulin-dependent protein kinase II (CaMKII) activity and its phosphorylation in the hippocampal slices after NMDA receptor stimulation. Finally, we compared the expression of GluR1 and GluR2 AMPA receptor subunits with polysialylated form of neuronal cell adhesion molecule (PSA-NCAM) by the immunohistochemical technique because PSA-NCAM is involved in the neuronal plasticity associated with learning and memory. Furthermore, we investigated the phosphorylation of NMDA and AMPA receptor subunits after NMDA receptor stimulation in wild-type and the ORL 1 receptor knockout mice.
Materials and methods
We used male wild-type littermate and the male ORL 1 receptor knockout mice aged 9-12 weeks. 16 The animals were housed in a controlled environment (23711C, 5075% humidity) and were allowed food and water ad libitum. The room lights were on between 7:00 and 19:00. All experiments were performed in accordance with the Guidelines for Animal Experiments of the Nagoya University School of Medicine. The procedures involving animals and their care were conducted in conformity with the international guidelines 'Principles of Laboratory Animal Care' (NIH publication no. 85-23, revised 1985) .
Fear conditioning learning
Fear conditioning learning test was performed as described in previous reports. 17, 18 The conditioning chamber was in a soundproof box (90 cm Â 65 cm Â 60 cm). With the surrounding noise measuring 75 dB, noise within the box registered 68 dB. To provide background white noise (72 dB), a single computer fan was installed in one of the sides of the isolation chamber. The conditioning chamber (25 cm Â 30 cm Â 47 cm) is made of transparent Plexiglas with grid floor for footshock. The floor is removable, and after each experimental subject, it was cleaned with 70% ethanol. The floor grid is connected to a shockgenerator (NS-SG01; Neuroscience Inc., Tokyo, Japan), a device that delivers scrambled shocks. The chamber was surrounded by Scanet SV10-AQ (Melquest, Toyama, Japan), which is an apparatus that can measure automatically the immobility time using the digital counters with infrared cell sensors placed on the walls. We have checked that the freezing behavior is parallel with the immobility in our study (data not shown). The loud speaker used to deliver the conditioned stimulus (CS) is connected to a power supply with an adjustable current output that was kept constant throughout the experiments. For the cued and contextual conditioning experiments, each mouse was placed in the conditioning chamber for 1.5 min before the onset of the discrete CS (lasted 30 s at 2800 Hz and 85 dB of sound). In the last 2 s of CS, they were exposed to the unconditioned stimuli (US) (0.8 mA for 2 s of continuous foot shock). After the CS/US pairing, a mouse was left in the conditioning chamber for another 1 min and then placed back in their home cages. For contextual freezing, each mouse was placed in the experimental chamber in which the mice previously received a footshock. In this study, we measured the immobility at the 1st, 2nd or 7th day after the training, respectively. In the cued conditioned freezing, each mouse was placed in a novel context (new plastic cage with soft floor) for 2 min (pre-CS test), and then exposed to the CS for 2 min (CS test) 1, 2 and 7 days after the training, respectively. Nociceptin and [Nphe 1 ]nociceptin(1-13)-NH 2 were administered intracerebroventricularly in a volume of 5 ml per mouse. This volume is often used in many researches [10] [11] [12] and we confirmed no behavioral differences among saline treated, sham-treated and nontreated mice. 
H]MK-801 binding
Mice were killed by decapitation, and brains were quickly removed on an ice-cold glass plate. The forebrain (minus the cerebellum and brainstem) was rapidly dissected out, frozen and stored in a deep freezer at À801C until assayed. [ 3 H]MK-801 binding was measured as described previously. 19, 20 Briefly, frozen samples were thawed at room temperature and homogenized in 40 volumes of 50 mM Tris-acetate buffer (pH 7.4) containing 1 mM EDTA using a sonicator. All further procedures were performed at 41C. The homogenates were centrifuged at 40 000 Â g Nociceptin and memory T Mamiya et al for 30 min, and the resultant pellets were washed three times with the same volume of 50 mM Trisacetate buffer (pH 7.4). The final pellets were suspended in 30 volumes of 0.32 M sucrose, and the suspensions were frozen at -801C for no longer than 1 week until use. On the day of the experiments, the frozen suspensions were thawed at room temperature and treated with 0.08% Triton X-100 at 41C (an approximate protein concentration of 0.32 mg/ml) for 10 min with gentle stirring. The treatment was terminated by centrifugation at 40 000 Â g for 30 min, and the pellets were washed five times with 40 volumes of 50 mM Tris-acetate buffer (pH 7.4) followed by centrifugation at 40 000 Â g for 30 min. For determination of [ 3 H]MK-801 binding, an aliquot (0.3 mg of protein) of the membrane preparations was incubated in the presence or absence of glutamate (10 mM), glycine (10 mM) and spermidine (1 mM), with 5 nM ( þ ) [3- 3 H]MK-801 (22.5 Ci/mmol; NEN Life Science Products, Boston, MA, USA) in a total volume of 0.5 ml of 50 mM Tris-acetate buffer (pH 7.4) at 301C for 16 h. The incubation was terminated by rapid filtration through a Whatman GF/B glass filter under a constant vacuum. The filter was rinsed with 3 ml of ice-cold 50 mM Tris-acetate buffer three times within 10 s. Radioactivity retained on the filter was measured by a liquid scintillation spectrophotometry, at a counting efficiency of 57-59%. Nonspecific binding was defined by 0.1 mM cold ( þ ) MK-801 (Sigma, St Louis, MO, USA), and the specific binding accounted for more than 60% of the total binding found in the absence of cold ( þ ) MK-801. 45 Ca 2 þ Uptake 45 Ca 2 þ uptake assay was measured as described previously. 20 Mice were killed by decapitation, the brains were quickly removed, and the forebrain was dissected out on an ice-cold glass plate. The forebrains were homogenized in 20 volumes of ice-cold 0.32 M sucrose at 41C in a Teflon glass homogenizer. All further procedures were performed at 41C. The homogenates were centrifuged at 1000 Â g for 10 min. The supernatants were collected and then diluted 1:1 with basal buffer of the following composition: 135 mM NaCl, 5 mM KCl, 1 mM CaCl 2 and 10 mM HEPES, pH adjusted to 7.4 with Tris base, and centrifuged at 10 000 Â g for 15 min. The pellets were resuspended in basal buffer and used for the 45 
Ca
2 þ uptake assay. The synaptosomes suspension (0.5 mg of protein) was preincubated in a total volume of 450 ml of basal buffer, in the presence or absence of ( þ ) MK-801 (100 mM), at 371C for 10 min. The 45 Ca 2 þ uptake assay was initiated by adding 50 ml of prewarmed basal buffer containing 1 mCi/ml 45 CaCl 2 (18.1 mCi/mg; NEN Life Science Products), in the presence or absence of NMDA (100 mM), glycine (10 mM) and spermidine (1 mM) or high K þ (45 mM; isomolar replacement of NaCl with KCl). The reaction was terminated after 5 min by adding 3 ml of ice-cold basal buffer. The mixture was rapidly filtered under vacuum over Whatman GF/B glass filters, and the filters were rinsed twice with 3 ml of basal buffer. The radioactivity was determined by a liquid scintillation spectrophotometry at a counting efficiency of 90%. CaMKII activity assay CaMKII activity was determined according to the method described by Occur and Schulman, 21 and Colbran et al. 22 Hippocampi were dissected within 20 s and hippocampal slices (300 mm) were prepared using a Mcllwain Tissue chopper. After stimulation of NMDA receptor with NMDA (100 mM), glycine (10 mM) and spermidine (1 mM) for 5 min, the slices were sonicated in an ice-cold lysis buffer (35 mM HEPES-NaOH (pH 8.0), 1 mM EGTA, 10 mM sodium pyrophosphate, 0.4 mM sodium molybdate, 2 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 1 mM dithiothreitol (DTT)) at 41C. The homogenate was centrifuged at 100 000 Â g for 30 min and the resultant supernatant was subjected to the assay of CaMKII activity using syntide-2 as a synthetic substrate for CaMKII which is a 15-amino-acid peptide. The assay was carried out in the mixture (final volume of 50 ml) containing 35 mM HEPES-NaOH (pH 8.0), 10 mM MgCl 2 , 50 mM syntide-2, 10 mM [g- 32 P] ATP (500-900 cpm/pmol) and either 1 mM EGTA or 0.4 mM CaCl 2 and 10 mg/ml calmodulin. For determination of the total activity, 0.4 mM CaCl 2 , and 10 mg/ml calmodulin were added to the assay mixture; 1 mM EGTA was added to the basic mixture for determination of Ca 2 þ -independent activity. The mixtures were preincubated at 301C for 2 min, and all reactions were initiated by the addition of enzyme preparations. After incubation, aliquots of 10 ml were spotted onto P81 phosphocellulose paper. The papers were washed four times in 75 mM H 3 PO 4 and dried. Then, the radioactivity of samples was quantified by liquid scintillation counting.
Western blot analysis of CaMKIIa and GluR1 phosphorylation Hippocampal slices (300 mm) were prepared as described above. After stimulation of NMDA receptor with NMDA (100 mM), glycine (10 mM) and spermidine (1 mM) in the buffer (135 mM NaCl, 5 mM KCl, 1 mM CaCl 2 , 10mM HEPES-NaOH and 10 mM glucose, pH 7.4), the slices were homogenized by the sonication in an ice-cold lysis buffer (50 mM TrisHCl, 150 mM NaCl, 10 mM NaF, 10 mM EDTA, 1 mM sodium orthovanadate, 2 mg/ml pepstatin, 2 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mM PMSF, and 1 mM DTT, pH 7.4). Samples were boiled in Laemmli sample buffer, separated on a 7.5% polyacrylamide gel and subsequently transferred to PVDF membranes (Millipore). The membranes were blocked with Detector Block Kit (KPL) for 2 h at room temperature and then probed with antiphospho-CaMKIIa subunit (monoclonal anti-mouse peptide antibodies at 0.2 mg/ ml, ABR), antiphospho-GluR1 at Ser 831 (polyclonal anti-rabbit peptide antibodies at 0.2 mg/ml, Upstate Biotechnology) or antiphospho-GluR1 at Ser 845 (polyclonal anti-rabbit peptide antibodies at 0.2 mg/ml, Upstate Biotechnology) overnight at 41C. Membranes were washed with TBST buffer (10 mM Tris-HCl, 150 mM NaCl, 0.1% Tween 20, pH 7.4) and subsequently incubated with a goat anti-rabbit horseradish peroxidase-conjugated secondary antibody for 2 h at room temperature. The immune complexes were detected by chemiluminescence (ECL, Amersham) and exposed to X-ray film. The band intensities of film were analyzed by densitometry. To confirm equal loading of each protein, membranes were stripped with stripping buffer (62.5 mM Tris-HCl, 100 mM 2-mercaptoethanol, 2% SDS, pH 6.7) at 501C for 5 min, and then incubated with anti-CaMKIIa subunit antibody (monoclonal anti-mouse peptide antibodies at 0.2 mg/ml, ABR) or anti-GluR1 (antirabbit immunoaffinity-purified peptide antibodies at 0.2 mg/ml, Upstate Biotechnology) and detected as described above.
Immunoprecipitation of phosphorylated NR2B subunit Subsequent to NMDA receptor stimulation, the hippocampal slices were homogenized by sonication in an ice-cold lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 10 mM NaF, 10 mM EDTA, 1 mM sodium orthovanadate, 1% Nonidet P-40, 2 mg/ml pepstatin, 2 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mM PMSF and 1 mM DTT, pH 7.4). The lysate was centrifuged at 10 000 Â g for 10 min. Protein A-Sepharose (Amersham) was incubated with antiphosphoserine (polyclonal anti-rabbit peptide antibodies at 0.2 mg/ml, Zymed Laboratories Inc.) for 6 h and then incubated with lysate (500 mg protein) overnight. The immunoprecipitate was boiled in Laemmli sample buffer, separated on a 7.5% polyacrylamide gel and subsequently transferred to PVDF membranes (Millipore). Phosphorylated NR2B was detected with anti-NR2B antibodies (polyclonal antirabbit peptide antibodies at 0.2 mg/ml, Zymed Laboratories Inc.).
Immunocytochemical detection of polysialylated form of neuronal cell adhesion molecule (PSA-NCAM)
Coronal vibratome sections (75 mm) through the forebrain at the hippocampal level were made from five wild-type and five homozygous mutant brains (perfusion fixed with 4% paraformaldehyde). The floating sections were prepared for immunocytochemical analysis with a confocal laser scanning microscope (TCS, Leica, Heidelberg) as described previously. 23 The antibodies directed against PSA-NCAM (monoclonal mouse IgM, diluted 1:2000) were kindly donated by Dr T Seki, Juntendo University, Tokyo. To visualize also the environment of the PSA-NCAM positive cells, we used simultaneously antibodies against two other proteins strongly expressed in the hippocampus: the AMPA receptor subunits GluR-1 (polyclonal rabbit IgG, 1:200; Chemicon, Temecula, CA, USA) and GluR-2 (monoclonal mouse IgG, 1:60; Chemicon). Triple staining was performed using the following secondary antibodies: (1) CY3-conjugated donkey anti-mouse IgM (1:1000; Jackson Immuno Research, West Grove, PA, USA); (2) CY5-conjugated donkey anti-rabbit IgG (1:200; Jackson Immuno Research); (3) Fc-specific FITC-conjugated goat anti-mouse IgG (1:200; Sigma, St Louis, MO, USA). Serial 'optical slices' were recorded at different depth levels, and the resulting image stacks were processed to yield three-dimensional pictures that can be viewed with a standard stereo-lorgnette.
Data analysis
All results are expressed as means7SEM for each group. Statistical difference between groups was assessed with Dunnett multiple comparisons test. For the analysis of fear-conditioned memory test, we used analysis of variance (ANOVA) with repeated measures. Differences were considered statistically significant at a level of Po0.05.
Results
Fear conditioning learning and memory in the ORL 1 receptor knockout mice We tested the ORL 1 receptor knockout mice in the contextual fear conditioning learning and memory. Our previous reports show that there is no difference in the pain responses to the electric, chemical and thermal stimuli between the ORL 1 receptor knockout and wild-type mice. 12, 16 Wild-type and ORL 1 receptor knockout mice displayed comparable immobility when exposed to an electric footshock (conditioning) ( Figure 1A-a, -d) , demonstrating that the ORL 1 receptor knockout mice have no performance deficits, such as an inability to freeze. At 2 days after the conditioning, the ORL 1 receptor knockout and wild-type mice displayed the same degree of freezing response when they were exposed to the same context of the conditioning chamber ( Figure 1A b). At 7 days after the conditioning, the immobility time in wild-type mice was considerably decreased to about 50% and this immobility level was maintained at least up to the 14th day. On the other hand, the ORL 1 receptor knockout mice showed the immobility time as much as on the 2nd day, and were significantly higher than that in wild-type mice ( Figure 1A-c) . To evaluate the specificity of the enhancement of contextual memory, we tested the ORL 1 receptor knockout mice in the cued conditioned fear conditioning memory test, which does not require the hippocampal function in the rodents. In this test, on both the 2nd and 7th day, there was no difference in immobility time between the ORL 1 receptor knockout and wild-type mice in the presence or absence of tone ( Figure 1A-e, -f) .
In order to investigate the direct interaction between nociceptin system and NMDA receptor, the NMDA receptor antagonist ( þ ) MK-801 was administered in both the mice (Figure 1b) . The enhanced memory retention in the ORL 1 receptor knockout mice was blocked by ( þ ) MK-801 (0.03 mg/kg), while it did not affect the performance in wild-type mice ( Figure 1B-b) .
Effect of nociceptin on the fear conditioning learning and memory in wild-type mice To further investigate a role of nociceptin in learning and memory process, we examined the effect of intracerebroventricular injection (i.c. v.) of nociceptin in the fear conditioning learning and memory in wildtype mice. We chose the 2nd day to investigate the effects of nociceptin, because the immobility level on the 2nd day is approximately medial. As nociceptin (0.01 and 1 nmol/5 ml i.c.v.) was injected immediately after the 3-min conditioning, there was no difference in immobility during the conditioning among the three groups (Figure 2a and d) . Nociceptin had no effects on contextual freezing response on the 1st day (data not shown), but it induced a dose-dependent impairment of retention of contextual memory on the 2nd day (Figure 2b and c) . We have examined whether the effects of nociceptin are mediated through the ORL 1 receptor on the contextual memory by using [Nphe 1 ]nociceptin(1-13)-NH 2 , a selective ORL 1 receptor antagonist. The pretreatment of this antagonist inhibited the impairment of memory retention induced by nociceptin (Figure 2a-c) . In contrast, nociceptin failed to affect the cued conditioning memory (Figure 2e and f) .
NMDA receptor function in the hippocampus of the ORL 1 receptor knockout mice The present findings with our previous ones that LTP in the hippocampus are enhanced in the ORL 1 receptor knockout mice 13 suggest that NMDA receptor We next measured 45 Ca 2 þ uptake into synaptosomes through NMDA receptor (Figure 3b ). There was no difference in the basal 45 Ca 2 þ uptake into synaptosomes between wild-type and the ORL 1 receptor knockout mice. When the assay was performed in the presence of 100 mM NMDA, NMDA plus 10 mM glycine, NMDA, glycine plus 1 mM spermidine, 45 Ca 2 þ uptake was increased in both the groups. The 45 Ca 2 þ uptake in the ORL 1 receptor knockout mice was significantly higher than that in wild-type mice under the stimulated conditions with NMDA, glycine plus spermidine (Figure 3b) . The NMDA receptor agonist-stimulated CaMKII activity Ca 2 þ influx initiates a wide array of biochemical events associated with learning and memory in the synapse. 24, 25 One potential target for immediate activation by this Ca 2 þ influx is CaMKII. 26 Since CaMKII has long been known to be essential for the expression of both LTP and memory, 27 we examined CaMKII activity. When CaMKII was preincubated under conditions promoting Ca 2 þ -dependent autophosphorylation and subsequently assayed, the activity detected in the presence of excess of EGTA (Ca 2 þ -independent activity) increased in a time-dependent manner and reached a maximum at about 1 min as previously reported. 28 Thus, we examined the CaMKII activity after 1-min preincubation. The activity assayed in the presence of Ca 2 þ and CaM (total activity) was not different between wild-type (19.273.1 nmol/min/mg protein) and the ORL 1 re- CaMkII activity (% of control) Figure 4 Ca 2 þ -independent CaMKII activity in wild-type and the ORL 1 receptor knockout mice. Hippocampal slices were incubated in the presence or absence of 100 mM NMDA plus 10 mM glycine plus 1 mM spermidine for 5 min and then CaMKII activity was determined. ( þ ) MK-801 (300 mM) was pretreated for 2 min before the NMDA receptor stimulation. Ca 2 þ -independent CaMKII activity in wild-type and the ORL 1 2 þ -independent CaMKII activity was not affected by NMDA alone (100 mM) in both the genotype mice, this activity was significantly increased when the assay was performed in the presence of 100 mM NMDA plus 10 mM glycine plus 1 mM spermidine (Figure 4) . The increased activity in the ORL 1 receptor knockout mice after NMDA receptor stimulation was significantly enhanced compared to that in wild-type mice. Additionally, the increased activities were inhibited by MK-801 in both the genotype mice.
Phosphorylation
CaMKIIa To support the data that CaMKII activity is facilitated after NMDA receptor stimulation, we examined the phosphorylation of CaMKIIa at Thr 286 in the hippocampal slices induced by NMDA receptor stimulation with 100 mM NMDA, 10 mM glycine plus 1 mM spermidine ( Figure 5 ). Under our experimental conditions, the phosphorylation of CaMKIIa at Thr 286 was detected after 5-min stimulation and remained for 30 min in the ORL 1 receptor knockout mice. On the other hand, in wild-type mice the phosphorylation was observed after 20-min stimulation of NMDA receptor. These results show that the rapid phosphorylation of CaMKIIa at Thr 286 is induced in the ORL 1 receptor knockout mice compared with wild-type mice. We also examined the effects of exogenous nociceptin on NMDAinduced CaMKIIa phosphorylation. Hippocampal slices from wild-type mice were preincubated with pertussis toxin (5, 50 and 500 ng/ml for 16 h) and/or nociceptin (10 mM) for 10 min before 20-min NMDA receptor stimulation ( Figure 6 ). 29 In our experiment, the inhibitory effects of pertussis toxin (50 ng/ml) showed the maximal effects. Nociceptin inhibited significantly the phosphorylation of CaMKIIa induced by NMDA receptor stimulation (Figures 5b  and 6) . Furthermore, the pretreatment of pertussis toxin reversed the inhibitory effect of nociceptin on the NMDA-induced phosphorylation of CaMKIIa. These results suggest that nociceptin negatively regulates the phosphorylation of CaMKIIa induced by NMDA receptor stimulation through pertussis toxin-sensitive G proteins.
GluR1 and NR2B
One target for regulation by CaMKII may be the AMPA-type glutamate receptor subunit GluR1. 15 (Figure 7a and b) .
Another target for regulation by CaMKII may be the NMDA receptor itself, especially NR2B subunit at Ser 1303 32,33 Thus, we also compared the phosphoryla- tion of NMDA receptor subunit NR2B at Ser 1303 after NMDA receptor stimulation in both the genotype mice at various points (Figure 7c) . The NR2B at Ser 1303 was phosphorylated by NMDA receptor stimulation in both the genotype mice. No differences were observed in the phosphorylation levels between wild-type and the ORL 1 receptor knockout mice.
Polysialylated form of neuronal cell adhesion molecule (PSA-NCAM) and GluR 1/2 expression While there was few if any PSA-NCAM detectable in neocortical areas (data not shown), the protein was present in the hippocampal complex, and particularly in the dentate gyrus of both wild-type and the ORL 1 receptor knockout mice (Figure 8 ). The density of PSA-NCAM positive processes in the dentate polymorph layer, and the number of cell bodies within this layer as well as in the granular layer, were reduced in the ORL 1 receptor knockout (Figure 8b ) as compared with wild-type mice (Figure 8a ). Expressions of both GluR1 and GluR2 in the ORL 1 receptor knockout were not changeable compared to the wildtype mice.
Discussion
Previously, we have reported that LTP in the hippocampus and memory is facilitated in the ORL 1 receptor knockout mice compared to the wild-type mice. [11] [12] [13] Moreover, exogenous nociceptin has been reported to impair learning and memory in intact mice 10, 11 and in rats. 8, 9 Here we investigated the mechanisms of nociceptin-induced modulation in learning and memory.
First of all, we examined the contextual and cued conditioning response to see whether the enhancement of learning and memory in the ORL 1 receptor knockout mice is dependent on the hippocampal NMDA receptor function. The NMDA receptor in the hippocampus plays an important role in the contextual, but not cued conditioning memory. 14, [34] [35] [36] In the ORL 1 receptor knockout mice, the retention of contextual fear conditioning memory was prolonged without any alterations of cued conditioning response. The enhancement of memory retention in the ORL 1 receptor knockout mice was observed compared with wild-type mice on the 7th day when the immobility time was approximately B50% in the Figure 8 Three-dimensional representation of wild-type (a) and the ORL 1 receptor knockout (b) dentate gyrus, to be viewed with a stereo-lorgnette. Reconstruction using nine serial 'optical sections' taken at 1 mm intervals. Five mice were used independently in each group. Coronal sections. Dorsal is up; median is to the left. Coded in red: PSA-NCAM; blue: GluR-1; green: GluR-2. Note the reduction of red-coded processes and cells in the ORL 1 receptor knockout dentate gyrus (b).
wild-type mice, but not on the 2nd day when the immobility time was about B80% in wild-type mice. The lack of significant difference between the genotypes on the 2nd day may be because of the ceiling effect in this task. On the other hand, nociceptin (1 nmol) induced an impairment of the contextual, but not cued conditioning memory. This acute effect of nociceptin on the contextual memory in wild-type mice was examined on the 2nd day (Figure 2) , because the level of immobility time was relatively small on the 7th day so that the inhibitory effects of nociceptin may not be detected because of the floor effects. These results confirmed our previous results that exogenous nociceptin impaired not only the acquisition but also the retention in the passive avoidance test, and that the ORL 1 receptor knockout mice showed an enhancement of the memory retention in the passive avoidance test. 11, 13 Importantly, the impairment by nociceptin was blocked by a selective ORL 1 receptor antagonist. Furthermore, the enhancement of retention memory on the 7th day in the ORL 1 receptor knockout mice was blocked by an NMDA receptor antagonist, ( þ ) MK-801. Collectively, our findings suggest that (1) nociceptin system is involved in the regulation of memory retention and (2) the effects of nociceptin in learning and memory are mediated via NMDA receptor in the hippocampal function. In the previous reports, basal nociceptin contents have been reported to be 55.5-58.7 pg/ml (614-648 fmol/rat) in the brain of rat. 37 The dose of nociceptin used in the present study (1 nmol/mouse) is far higher than basal nociceptin contents in the brain, but is comparable to antinociceptive doses. 2, 3 Thus, it is considered that nociceptin (0.01-1 nmol) impairs cognitive function at pharmacological doses.
Previous studies demonstrated that enhanced LTP in the hippocampus of the ORL 1 receptor knockout mice was blocked by NMDA receptor antagonist, indicating a role of NMDA receptor. No difference between genotypes in the paired-pulse facilitation suggests that the ORL 1 receptors modulate LTP probably through the postsynaptic mechanisms, 13 because paired-pulse facilitation is used as an index of the efficacy of releasing neurotransmitters from presynapse. Furthermore, nociceptin was reported to function as an inhibitory modulator for synaptic function in the hippocampus. 6 Accordingly, we examined the effects of nociceptin on the NMDA receptor function and signal transduction through NMDA receptor. NMDA receptor is a ligand and voltage-gated Ca 2 þ channel. Binding of glutamate released from the presynaptic terminal, coupled with strong depolarization of the postsynaptic membrane produces an influx of Ca 2 þ into the postsynaptic compartment. This Ca 2 þ influx initiates a wide array of biochemical events in the synapse that can lead to LTP or LTD. 24, 25 One potential target for immediate activation by this Ca 2 þ influx is CaMKII. 26 CaMKII has long been known to be essential for the expression of both LTP and LTD. 38 20 Accordingly, these results suggest that the function of NMDA receptor in the ORL 1 receptor knockout mice is potentiated.
The reduction of CaMKII activity by pharmacological 41 or genetic 38 means impairs LTP and learning, whereas injecting or overexpressing CaMKII increases synaptic strength, which occludes and is occluded by electrically induced LTP. 39, 42 Crucial to its function in LTP and spatial learning, 27, 43 CaMKII at Thr 286 undergoes rapid phosphorylation following NMDA receptor-mediated calcium influx. Since this autophosphorylation renders the kinase calcium independent and has been proposed as a form of molecular memory, 44 we examined the CaMKII activity. NMDA receptor stimulation with NMDA, glycine and spermidine increased the CaMKII activity in both the wild-type and the ORL 1 receptor knockout mice, the increased activity in the ORL 1 receptor knockout mice was significantly enhanced compared with that in wild-type mice. The increased activities were inhibited by ( þ ) MK-801 in both the genotype mice. Furthermore, the rapid phosphorylation of CaMKIIa at Thr 286 was induced in the ORL 1 receptor knockout mice compared with wild-type mice. The phosphorylation was inhibited significantly by nociceptin, and pertussis toxin reversed the inhibitory effect of nociceptin on the NMDA-induced phosphorylation of CaMKIIa. Taken together, it is suggested that (1) NMDA receptor/CaMKII cascade is enhanced functionally in the ORL1 receptor knockout mice and (2) nociceptin regulates negatively NMDA-induced CaMKIIa phosphorylation through the pertussis toxin-sensitive G proteins.
One target for regulation by CaMKII at the postsynaptic site may be the AMPA-type glutamate receptor subunit GluR1, although uncertainty about the topology of receptor folding has cast some doubt on the significance of direct phosphorylation of GluR1 in vivo. 15, 30, 31 We could not observe any difference of both GluR1 and GluR2 expression in the hippocampus between wild-type and the ORL 1 receptor knockout mice. By the activation of NMDA receptor with 100 mM NMDA, 10 mM glycine plus 1 mM spermidine, in both the genotype mice, GluR1 at Ser 831 was phosphorylated, but there was no difference between the two genotypes. GluR1 at Ser 845 was not significantly phosphorylated under our conditions. Another target for regulation by CaMKII at postsynaptic site may be the NMDA receptor itself, especially NR2B subunit at Ser 1303 . 32, 33 After NMDA receptor stimulation, we detected increased phosphorylation of NR2B at Ser 1303 , but there was no significant difference between wild-type and the ORL 1 receptor knockout mice. Accordingly, molecular targets of NMDA receptor/CaMKII cascade which are responsible for the hyperfunction of NMDA receptor in the ORL 1 receptor knockout mice remain to be determined.
As one of the possibilities, abnormalities of the signal-transduction systems involving protein kinase C (PKC) or mitogen-activated protein (MAP) kinases may contribute to an enhancement of learning and memory in the ORL 1 receptor knockout mice. Previous studies have indicated that PKC modulates CA1 LTP and learning, 45, 46 and is activated by stimulation of the ORL 1 receptor. 29 However, PKC activity was not affected by the lack of the ORL 1 receptor in the nonstimulated condition (unpublished data). Alternatively, MAP kinase activity increases in the hippocampus during fear conditioning. 47 We also failed to detect any differences in the MAP kinase phosphorylation of ERK1 and ERK2 when the NMDA receptor was stimulated by 100 mM NMDA, 10 mM glycine plus 1 mM spermidine (unpublished data). Further studies are necessary to elucidate the involvement of PKC and MAP kinases in the modulation of learning and memory by nociceptin.
The polysialylated form of NCAM (PSA-NCAM) is strongly expressed in the embryonic nervous system during cell migration and neurite extension. In the adult brain, PSA-NCAM is still present in a few restricted areas, including the hippocampus. 48 The presence of PSA-NCAM in the adult hippocampus has been associated with neural plasticity 49 involved in learning processes. 50 In the hippocampus, PSA-NCAM may support migration of newly formed neurons that will settle in the dentate granular layer. Alternatively, it may be necessary for the movement of cell processes linked to adult neurogenesis or to plasticity of established cells. It seemed therefore interesting to have a look at this protein in the hippocampal complex of the ORL 1 receptor knockout as compared with the wild-type mice.
We found that PSA-NCAM expression was reduced in the ORL 1 receptor knockout mice. With regard to this unexpected findings, we have previously reported that the lack of telencephalin, one of NCAMs induces the facilitation of LTP in the hippocampus and the enhancement of learning and memory without affecting NMDA and non-NMDA receptor expression. 51 These characteristics in the telencephalin mutant mice are similar with those found in the ORL 1 receptor knockout mice. Regarding the interaction of NCAM and NMDA receptor, administration of NMDA receptor antagonist induces the expression of NCAM in the cortex and dentate gyrus. 52, 53 In addition, Bouzioukh et al. 54 have reported that the chronic blockade of NMDA receptor activation decreases the NCAM expression. Thus, these results suggest that NCAM expression is modulated by the NMDA receptor. Further studies are necessary to elucidate the role of PSA-NCAM in nociceptininduced modulation of learning and memory.
In conclusion, we found and confirmed the enhancement of memory retention with hyperfunction of NMDA receptor in the ORL 1 receptor knockout mice compared with wild-type mice. Moreover, exogenous nociceptin, which inhibited the activation of CaMKII induced by NMDA receptor stimulation through G proteins, impaired memory retention. In the ORL 1 receptor knockout mice, the expression of PSA-NCAM was reduced. These results suggest that nociceptin system negatively modulates learning and memory through the regulation of NMDA receptor function and the expression of PSA-NCAM.
